Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May 7;3(5):e2077.
doi: 10.1371/journal.pone.0002077.

The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study

Affiliations

The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study

Debby C J Vissers et al. PLoS One. .

Abstract

Background: Pre-exposure prophylaxis (PrEP) is a promising new HIV prevention method, especially for women. An urgent demand for implementation of PrEP is expected at the moment efficacy has been demonstrated in clinical trials. We explored the long-term impact of PrEP on HIV transmission in different HIV epidemics.

Methodology/principal findings: We used a mathematical model that distinguishes the general population, sex workers and their clients. PrEP scenarios varying in effectiveness, coverage and target group were modeled in the epidemiological settings of Botswana, Nyanza Province in Kenya, and Southern India. We also studied the effect of condom addition or condom substitution during PrEP use. Main outcome was number of HIV infections averted over ten years of PrEP use. PrEP strategies with high effectiveness and high coverage can have a substantial impact in African settings. In Southern India, by contrast, the number of averted HIV infections in different PrEP scenarios would be much lower. The impact of PrEP may be strongly diminished or even reversed by behavioral disinhibition, especially in scenarios with low coverage and low effectiveness. However, additional condom use during low coverage and low effective PrEP doubled the amount of averted HIV infections.

Conclusions/significance: The public health impact of PrEP can be substantial. However, this impact may be diminished, or even reversed, by changes in risk behavior. Implementation of PrEP strategies should therefore come on top of current condom campaigns, not as a substitution.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Effect of different PrEP scenarios and condom use on HIV prevalence.
A: Botswana, B: Nyanza province, Kenya. ‘PrEP low’ means 25% coverage and 50% effectiveness; ‘PrEP high’ means 75% coverage and 90% effectiveness; ‘Only CSW’ means target group is sex workers; ‘CSW&client’ means target group is sex workers and clients.
Figure 2
Figure 2. HIV prevalence in women in Southern India.
Depicted are the baseline fit and the effect of different PrEP scenarios and condom use. *NACO, 2005 ; **Kumar et al., 2006 ; ***Becker et al., 2007 . ‘PrEP low’ means 50% coverage and 50% effectiveness; ‘Only CSW’ means target group is sex workers; ‘Same’ means unchanged condom use during PrEP (90%); ‘Less’ means condom substitution during PrEP (condom use is 75% or 60%).

References

    1. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002:CD003255. - PubMed
    1. Hallett TB, Aberle-Grasse J, Bello G, Boulos LM, Cayemittes MP, et al. Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm Infect. 2006;82(Suppl 1):i1–8. - PMC - PubMed
    1. Ramjee G, Govinden R, Morar NS, Mbewu A. South Africa's experience of the closure of the cellulose sulphate microbicide trial. PLoS Med. 2007;4:e235. - PMC - PubMed
    1. Trial and failure. Nature. 2007;446:1. - PubMed
    1. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370:251–261. - PMC - PubMed